Characterization of Methadone Overdose: Clinical Considerations and the Scientific Evidence
Cyclosporin Monitoring in Australasia: Survey of Laboratory Practices in 2000
Comparison of Trough, 2-Hour, and Limited AUC Blood Sampling for Monitoring Cyclosporin (Neoral®) at Day 7 Post–Renal Transplantation and Incidence of Rejection in the First Month
The Pharmacokinetics of Nelfinavir in HIV-1—Infected Children
Extremely Prolonged Elimination of Cibenzoline at Toxic Plasma Concentrations in Patients With Renal Impairments
Influence of Menstrual Cycle on the Pharmacokinetics of Paracetamol Through Salivary Compartment in Healthy Subjects
Serious Neutropenia in ALL Patients Treated With L-Asparaginase May Be Avoided by Therapeutic Monitoring of the Enzyme Activity in the Circulation
Interference of Hematocrit in the Tacrolimus II Microparticle Enzyme Immunoassay
Free and Glucuronidated Olanzapine Serum Concentrations in Psychiatric Patients: Influence of Carbamazepine Comedication
Therapeutic Drug Monitoring Data on Olanzapine and Its N-Demethyl Metabolite in the Naturalistic Clinical Setting
Population Pharmacokinetics and Relationship Between Demographic and Clinical Variables and Pharmacokinetics of Gentamicin in Neonates
Pharmacokinetic and Pharmacodynamic Effects of Clonazepam in Children With Epilepsy Treated With Valproate: A Preliminary Study
Simultaneous Determination of Seven Tricyclic Antidepressant Drugs in Human Plasma by Direct-Injection HPLC-APCI-MS–MS With an Ion Trap Detector
Therapeutic Drug Monitoring of Racemic Venlafaxine and Its Main Metabolites in an Everyday Clinical Setting
Simultaneous Quantitative Assay of Six HIV Protease Inhibitors, One Metabolite, And Two Non-Nucleoside Reverse Transcriptase Inhibitors in Human Plasma by Isocratic Reversed-Phase Liquid Chromatography
Relationship Between Plasma Concentrations of Trazodone and Its Active Metabolite, m-Chlorophenylpiperazine, and Its Clinical Effect in Depressed Patients
Very Long Half-Life of Paroxetine Following Intoxication in an Extensive Cytochrome P4502D6 Metabolizer
Pharmacokinetic Interaction Between High-Dose Methotrexate and Oxacillin
Trough Levels of Tacrolimus
Commentary
Pharmacokinetic Evaluation of Indinavir and Indinavir/Ritonavir-Containing Antiretroviral Regimens in a Clinical Setting